Peripheral Neuropathy Symptoms, Pain and Functioning in Relapsed or Refractory Multiple Myeloma Patients Treated with Selinexor, Bortezomib, and Dexamethasone

Introduction: The BOSTON study is a Phase 3 trial comparing the novel triplet regimen of once weekly oral selinexor with once weekly bortezomib and dexamethasone (SVd) versus standard twice weekly Vd in patients with multiple myeloma (MM) after 1-3 prior therapies. The SVd regimen conferred a 47% in...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2020-11, Vol.136 (Supplement 1), p.39-41
Hauptverfasser:	Sanchez, Larysa, Leleu, Xavier, Beaumont, Jennifer, Yu, Hailin, Hudgens, Stacie, Auner, Holger W, Quach, Hang, Delimpasi, Sosana, Spicka, Ivan, Pour, Luděk, Dimopoulos, Meletios A, Pylypenko, Halyna, Doronin, Vadim A, Usenko, Ganna, Hajek, Roman, Benjamin, Reuben, Venner, Christopher P., Garg, Mamta, Stevens, Don A., Jagannath, Sundar, Moreau, Philippe, Levy, Moshe, Bahlis, Nizar J., Facon, Thierry, Chai, Yi, Ma, Xiwen, Tang, Shijie, Leong, Hoyee, Shah, Jatin J., Shacham, Sharon, Kauffman, Michael G, Richardson, Paul G., Grosicki, Sebastian
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!